KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $1.11.

  • Charles River Laboratories International's EPS (Basic) fell 1716.42% to $1.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.52, marking a year-over-year decrease of 11888.2%. This contributed to the annual value of $0.2 for FY2024, which is 9783.81% down from last year.
  • Per Charles River Laboratories International's latest filing, its EPS (Basic) stood at $1.11 for Q3 2025, which was down 1716.42% from $1.06 recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's EPS (Basic) peaked at $3.69 during Q4 2022, and registered a low of -$4.2 during Q4 2024.
  • Over the past 5 years, Charles River Laboratories International's median EPS (Basic) value was $1.76 (recorded in 2021), while the average stood at $1.55.
  • As far as peak fluctuations go, Charles River Laboratories International's EPS (Basic) skyrocketed by 4959.35% in 2022, and later plummeted by 21501.68% in 2024.
  • Over the past 5 years, Charles River Laboratories International's EPS (Basic) (Quarter) stood at $2.73 in 2021, then soared by 35.16% to $3.69 in 2022, then fell by 1.08% to $3.65 in 2023, then crashed by 215.02% to -$4.2 in 2024, then skyrocketed by 126.44% to $1.11 in 2025.
  • Its EPS (Basic) was $1.11 in Q3 2025, compared to $1.06 in Q2 2025 and $0.5 in Q1 2025.